0 items USD 0.00Search
- Did you mean
- non small cell long cancer
Your search for "non small cell lung cancer" gave back 111 results.
As the global economy recovers in 2021 and the supply of the industrial chain improves, the Breast Cancer Molecular Diagnostics market will undergo...
Catalog:
Arsta
January 2023
Price: USD 3,490.00
As the global economy recovers in 2021 and the supply of the industrial chain improves, the Muscle Invasive Bladder Cancer Treatment market will...
Catalog:
Arsta
January 2023
Price: USD 3,490.00
Antibody-Drug Conjugate Pipeline Review by target, drug, phase and company The competitive intelligence report „ Antibody-Drug Conjugate Pipeline...
Catalog:
La Merie Publishing
December 2016
Price: USD 880.00
This report describes and analyzes the situation of antibody-drug conjugates as of November 2015 regarding: ADC pipeline, ADC technologies, ADC...
Catalog:
La Merie Publishing
November 2015
Price: USD 2,500.00
Summary Prostate Cancer Diagnostics market research report provides the newest industry data and industry future trends, allowing you to identify the...
Catalog:
ICRW
February 2019
Price: USD 2,960.00
Worldwide markets are poised to achieve continuing growth as the artificial intelligence software increases diagnostic excellence, saving lives and...
Catalog:
WinterGreen Research
October 2017
Price: USD 4,200.00
Ever since the establishment of the genetic basis of life, researchers have tried to manipulate genes in plants and animals to improve traits. There...
Catalog:
IQ4I
September 2016
Price: USD 4,950.00
The Competitive Intelligence report about Nonalcoholic Steatohepatitis (NASH) - Novel Drug Candidates provides a competitor analysis in the...
Catalog:
La Merie Publishing
January 2015
Price: USD 249.00
VEGF Antibodies – Bevacizumab and Ranibizumab Biosimilars and Biosuperiors The present Competitive Intelligence Report about VEGF Antibodies –...
Catalog:
La Merie Publishing
February 2014
Price: USD 401.00
This Competitive Intelligence Report about VEGF and VEGF-R Antibodies 2015 - Biosimilars and Biosuperiors of Avastin and Lucentis provides a...
Catalog:
La Merie Publishing
February 2015
Price: USD 460.00
This Competitive Intelligence Report about Specific and Bispecific Her3 Antibodies provides a competitor evaluation in the field of recombinant...
Catalog:
La Merie Publishing
February 2015
Price: USD 260.00
This Competitive Intelligence report prepared by La Merie Business Intelligence provides a compilation of the sales data of recombinant therapeutic...
Catalog:
La Merie Publishing
March 2015
Price: USD 140.00
The present Competitive Intelligence Report about Her2 Antibodies - Trastuzumab Biosimilars and Biobetters/Biosuperiors provides a competitor...
Catalog:
La Merie Publishing
February 2014
Price: USD 413.00
Competitor Analysis: Anti-VEGF and Anti-VEGF-R Biosimilars and Biosuperiors of Avastin, Cyramza, Eylea and Lucentis – a 2017 Update The Competitive...
Catalog:
La Merie Publishing
November 2017
Price: USD 525.00
This report studies the life science instruments and reagents market over the forecast period of 2017 to 2023. The life science instruments and...
Catalog:
IQ4I
February 2017
Price: USD 5,400.00
